Augmedics Names Tal Davidson as New VP of R&D, Bolsters Team after Acquisitions and New Funding
-
Augmedics appoints Tal Davidson, MD as new VP of R&D. Davidson was previously AI Research Director at Medtronic.
-
The news comes after Augmedics acquired IP and assets from Surgalign and Holo Surgical.
-
Augmedics CEO says Davidson's experience in visualization and AI will help build the next generation of the xvision platform.
-
Augmedics recently closed an $82.5 million financing round.
-
The company's xvision Spine System has been used to treat over 4,500 patients and implant over 25,000 pedicle screws.